Attachment 6 - Solicitation BPA Agilent TapeStation.docx

Attachment 6 – Solicitation BPA Agilent TapeStation Blanket Purchase Agreement – Agilent 4150 TapeStation System, Consumables, Accessories, and Maintenance Services Section 1 – General Information & Summary of Requirement This is a Request for Quotation (RFQ) for commercial products prepared in accordance with the commercial acquisition procedures of FAR Part 12. The Solicitation number is HFP-2026-133932. The NAICS Code for this requirement is 334516.

This acquisition is a total small business set aside.

The small business size standard for this NAICS code is 1,000 employees. The full table of size standards is available at: https://www.sba.gov/document/support-table-size-standards Description of Requirement:

The U.S. Food and Drug Administration (FDA), Office of Applied Microbiology and Technology (OAMT), has a requirement to establish a five (5) year Blanket Purchase Agreement (BPA) to support the procurement of one (1) Agilent 4150 TapeStation System Bundle (Model G2992A), with the ability to purchase additional units, proprietary ScreenTape consumables, accessories, replacement parts, and associated maintenance and support services throughout the full five-year period of performance, as outlined in Attachment 1 - Statement of Work (SOW).

OAMT currently operates Agilent TapeStation instrumentation integrated into validated standard operating procedures (SOPs), quality control workflows, and ongoing genomic microbiology research protocols. The laboratory relies on the Agilent TapeStation platform for DNA and RNA quality control analysis, including determination of nucleic acid concentration, fragment size distribution, and integrity prior to downstream applications including next-generation sequencing (NGS), whole genome microarray, and quantitative polymerase chain reaction (qPCR) workflows.

Establishment of this BPA will allow OAMT to:

Procure one (1) Agilent 4150 TapeStation System as the initial requirement under the BPA, with the ability to order additional units as laboratory needs evolve.

Place additional orders for consumables, accessories, and maintenance services throughout the five-year period of performance on an as-needed basis via individual BPA calls.

Reduce administrative burden associated with repetitive procurements for proprietary Agilent products and services.

Ensure continuity of laboratory operations and validated workflows over the full five-year period of performance.

The BPA will cover the following five (5) categories of products and services:

Category 1: Agilent TapeStation Instrumentation Category 2: Proprietary Agilent ScreenTape Consumables and Reagents Category 3: Accessories, Replacement Parts, and Ancillary Supplies Category 4: Maintenance and Support Services (Agilent CrossLab Silver Service Plan) Category 5: Software, Firmware, and Software Support Services Section 2 – Period of Performance / Delivery The period of performance for this BPA is five (5) continuous years from the effective date of BPA award. There are no option years. The BPA shall remain active and available for use by the Government for the full five-year period.

Initial Instrument Delivery:

The contractor shall deliver one (1) Agilent 4150 TapeStation System Bundle (Model G2992A) as the initial BPA call no later than 30 calendar days after BPA award, to the location specified in Section 7 of the SOW. Delivery shall include installation, initial operational verification, and all items specified under Category 1 of the SOW.

Subsequent BPA Calls – Order Fulfillment Timeframes:

The Government will issue individual BPA calls against this agreement on an as-needed basis throughout the five-year period of performance. Standard order fulfillment timeframes are as follows:

Warranty and Maintenance Transition:

Each Agilent 4150 TapeStation System Bundle delivered under this BPA shall include a manufacturer's warranty. The Agilent CrossLab Silver Service Plan (Category 4) shall commence upon expiration of the manufacturer's warranty for each covered instrument and shall be ordered via individual BPA calls as applicable.

Section 3 – Contract Line Items (CLINs) All prices shall be fully loaded and inclusive of all costs associated with performance, including equipment, software, consumables, accessories, delivery, installation, labor, travel, and parts. A single firm-fixed unit price is required for each line item, valid for the full five-year period of performance. Vendors shall not leave any field blank; if an item does not apply, enter $0.00 and provide a written explanation. See the attached BPA Pricing Schedule for the complete fillable pricing instrument.

Section A – Category 1: Agilent TapeStation Instrumentation

CLIN 1003 – Vendor Model and Description: _ Section B – Category 2: ScreenTape Consumables and Reagents B.1 – DNA ScreenTape Assay Kits

B.2 – RNA ScreenTape Assay Kits

B.3 – Additional Consumables

CLINs 2018–2020 – Vendor Item Description: _ Section C – Category 3: Accessories, Replacement Parts, and Ancillary Supplies

CLINs 3004–3006 – Vendor Item Description: _ Section D – Category 4: Maintenance and Support Services D.1 – CrossLab Silver Service Plan

Vendor – Description of Service Plan Exclusions (if any): _ Section E – Category 5: Software, Firmware, and Software Support Services

Vendor – Software and Firmware Services Included in CrossLab Silver Service Plan: _ Section F – Pricing Escalation Methodology Vendors shall indicate their proposed pricing approach below. All unit prices shall be firm-fixed for the full five-year period of performance.

☐ Firm-Fixed Unit Prices for Full 5-Year Period (Preferred)

☐ Other (describe below)

Section G – Total BPA Price Summary The table below summarizes the firm-fixed unit prices established under this BPA. This summary represents the ceiling unit prices the Government may order against for the full five-year period of performance. Total values are estimates based on a single unit of each line item and do not represent a guaranteed purchase commitment.

Total Estimated BPA Value – Full 5-Year Period

Section H – Vendor Representations and Certifications By submitting this pricing schedule, the Vendor represents and certifies that:

All unit prices submitted are accurate, complete, and shall remain valid for the full five-year period of performance from the BPA effective date.

All products provided under this BPA will be new, genuine Agilent OEM products unless otherwise specified and approved in writing by the Government POC.

The vendor is a current, authorized Agilent reseller and/or service provider and will maintain that status for the full five-year period of performance. The vendor shall notify the Government immediately and in writing if authorized reseller or service provider status is revoked or lapses for any reason.

The vendor acknowledges that the Government does not guarantee any minimum purchase quantity under this BPA and that all orders will be placed via individual BPA calls at the sole discretion of the Government.

The vendor acknowledges that unit prices submitted herein represent the maximum prices that may be charged to the Government under this BPA for the full five-year period of performance.

Section 4 – Points of Contact Contracting Officer:

- Name: Michele Jackson

- Email: Michele.Jackson@FDA.HHS.GOV

- Phone: “To be provided at award” Contracting Officer's Representative (COR):

- Name: “To be provided at award”

- Email: “To be provided at award”

- Phone: “To be provided at award” Section 5 – Contract Clauses Clauses Incorporated by Reference 52.252-2 – Clauses Incorporated By Reference (Feb 1998) This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this/these address(es):

- https://acquisition.gov

- https://acquisition.gov/far-overhaul

- https://acquisition.gov/hhsar (End of clause) The following clauses apply:

Clauses Incorporated by Full Text 52.217-8 – Option to Extend Services (Mar 2000) The Government may require continued performance of services within the limits and rates specified in the contract. The option may be exercised more than once but shall not exceed six months.

(End of Clause) ________________________________________ (End of clause) FDA Electronic Invoicing and Payment Requirements – Invoice Processing Platform (IPP) (JAN 2022)

a. All invoice submissions for goods and/or services must be made electronically through the U.S. Department of Treasury's Invoice Processing Platform System (IPP). http://www.ipp.gov/vendors/index.htm

b. Invoice Submission for Payment means any request for contract financing payment or invoice payment by the Contractor. To constitute a proper invoice, the payment request must comply with the requirements identified in FAR 32.905(b), "Content of Invoices" and the applicable Payment clause included in this contract, or the clause 52.212-4 Contract Terms and Conditions – Commercial Products and Commercial Services included in commercial item contracts. The IPP website address is: https://www.ipp.gov

c. The Agency will enroll Contractors new to IPP. The Contractor must follow the IPP registration email instructions for enrollment to register the Collector Account for submitting invoice requests for payment. The Contractor Government Business Point of Contact (as listed in SAM) will receive a Registration email from the Federal Reserve Bank of St. Louis (FRBSTL) within 3–5 business days of contract award for new contracts or date of modification for existing contracts. Registration emails are sent via email from ipp.noreply@mail.eroc.twai.gov. Contractor assistance with enrollment can be obtained by contacting the IPP Production Helpdesk via email to IPPCustomerSupport@fiscal.treasury.gov or phone (866) 973-3131. The Contractor POC will receive two emails from IPP Customer Support. The first email contains the initial administrative IPP User ID. The second email, sent within 24 hours of the first, contains a temporary password. You must log in with the temporary password within 30 days. If your company is already registered to use IPP, you will not be required to re-register. If the Contractor is unable to comply with the requirement to use IPP for submitting invoices for payment as authorized by HHSAR 332.7002, a written request must be submitted to the Contracting Officer to explain the circumstances that require the authorization of alternate payment procedures.

d. Invoices that include time-and-materials or labor-hour line items must include supporting documentation to (1) substantiate the number of labor hours invoiced for each labor category, and (2) substantiate material costs incurred (when applicable).

e. Contractor is required to attach an invoice log addendum to each invoice which shall include, at a minimum: (1) a list of all invoices submitted to date under the subject award, including invoice number, amount, and date submitted, as well as corresponding payment amount and date received; (2) total amount of all payments received to date under the subject contract or order; and (3) for definitized contracts or orders only, total estimated amounts yet to be invoiced for the current, active period of performance.

f. Payment of invoices will be made based upon acceptance by the Government of the entire task or the tangible product deliverable(s) invoiced. Payments shall be based on the Government certifying that satisfactory services were provided, and the Contractor has certified that labor charges are accurate.

g. If the services are rejected for failure to conform to the technical requirements of the Order, or any other contractually legitimate reason, the Contractor shall not be paid, or shall be paid an amount negotiated by the CO.

h. Questions regarding invoice payments that cannot be resolved by the IPP Helpdesk should be directed to the FDA Employee Resource and Information Center (ERIC) Helpdesk at 301-827-ERIC (3742) or toll-free 866-807-ERIC (3742); or by email at ERIC@fda.hhs.gov. When emailing, please include the contract number, invoice number and date, your name, phone number, and a detailed description of the issue.

HHSAR 352.203-70 Anti-Lobbying Jun 2026 303.808-70 Anti-Lobbying (DEC 2015) Pursuant to the HHS annual appropriations acts, except for normal and recognized executive-legislative relationships, the Contractor shall not use any HHS contract funds for:

(a) Publicity or propaganda purposes;

(b) The preparation, distribution, or use of any kit, pamphlet, booklet, publication, electronic communication, radio, television, or video presentation designed to support or defeat the enactment of legislation before the Congress or any State or local legislature or legislative body, except in presentation to the Congress or any state or local legislature itself; or designed to support or defeat any proposed or pending regulation, administrative action, or order issued by the executive branch of any state or local government, except in presentation to the executive branch of any state or local government itself; or

(c) Payment of salary or expenses of the Contractor, or any agent acting for the Contractor, related to any activity designed to influence the enactment of legislation, appropriations, regulation, administrative action, or Executive order proposed or pending before the Congress or any state government, state legislature or local legislature or legislative body, other than for normal and recognized executive-legislative relationships or participation by an agency or officer of a state, local, or tribal government in policymaking and administrative processes within the executive branch of that government.

(d) The prohibitions in subsections (a), (b), and (c) above shall include any activity to advocate or promote any proposed, pending, or future federal, state, or local tax increase, or any proposed, pending, or future requirement for, or restriction on, any legal consumer product, including its sale or marketing, including, but not limited to, the advocacy or promotion of gun control.

(End of clause) Section A – Solicitation Provisions Provisions Incorporated by Reference 52.252-1 – Solicitation Provisions Incorporated by Reference (Feb 1998) This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The vendor is cautioned that the listed provisions may include blocks that must be completed by the vendor and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the vendor may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at this/these address(es):

- https://acquisition.gov

- https://acquisition.gov/far-overhaul

- https://acquisition.gov/hhsar (End of provision) The following provisions apply:

Provisions Incorporated by Full Text

352.239-78 Information and Communication Technology Accessibility Notice (FEB 2024 Deviation)

Section B – Evaluation Basis for Award Award will be made to the lowest-priced vendor whose quote is determined to be technically acceptable. Technical acceptability will be determined on a pass/fail basis against the salient characteristics and minimum requirements of the requirement. Quotations that do not meet all salient characteristics will be determined technically unacceptable and will not be considered for award. Price will be evaluated for reasonableness.

The Government will evaluate quotations against the following factors:

· Technical Capability: The vendor's demonstrated ability to provide genuine Agilent OEM products and services across all five (5) categories for the full five-year period of performance, including compatibility with Government-owned Agilent TapeStation instrumentation and validated laboratory workflows, and compliance with all technical requirements specified in the attached SOW.

· Authorized Status: Confirmation that the vendor is a current, authorized Agilent reseller and/or service provider, with the ability to maintain that status for the full five-year period of performance.

· Past Performance: References were 3 to 5 years prior and applicable to this requirement and evaluated as acceptable, neutral or unacceptable

· Price: Evaluated for reasonableness and completeness across all CLINs. All unit prices must be firm-fixed for the full five-year period of performance The Government will evaluate offers for award purposes by considering the total estimated BPA value across all five categories for the full five-year period of performance. Quotations that do not meet all technical requirements and salient characteristics specified in the attached SOW will be determined technically unacceptable and will not be considered for award.

Section C – Instructions to Vendors 52.212-1 – Instructions to Vendors—Commercial Products and Commercial Services (NOV 2025) Applies in its entirety except as modified below Addendum to FAR 52.212-1.

(a) Submission of offers. Submit signed and dated offers via email to Michele.Jackson@Fda.hhs.gov at or before the exact time specified in this solicitation. As a minimum, offers shall include—

1. The solicitation number;

2. The name, address, and telephone number of the Vendor;

3. The Vendor's Unique Entity Identifier (UEI) and, if applicable, Electronic Funds Transfer (EFT) indicator;

4. Information necessary to evaluate the factors contained in the provision at 52.212-2 or as described in the solicitation;

Responses to provisions that require Vendor completion of information, representations, and certifications (other than those collected via the System for Award Management (SAM)); and A statement specifying the extent of agreement with all terms, conditions, and provisions included in the solicitation and any solicitation amendments.

(b) Period for acceptance of offers. The Vendor agrees to hold the prices in its offer firm for 180 calendar days from the date specified for receipt of offers.

(c) Late submissions, modifications, revisions, and withdrawals of offers.

Vendors are responsible for submitting offers and any modifications or revisions to the Government office designated in the solicitation by the time specified in the solicitation.

Any offer, modification, or revision received after the time specified for receipt of offers is "late" and will not be considered unless it is received before award is made and the Contracting Officer determines that accepting the late offer would not unduly delay the acquisition. However, a late modification of an otherwise successful offer that makes its terms more favorable to the Government will be considered at any time it is received and may be accepted.

Vendors may withdraw their offers by written notice to the Government received at any time before award.

(d) BPA award. The Government intends to evaluate offers and award a BPA without discussions with vendors. Therefore, the Vendor's initial offer should contain the Vendor's best terms. However, the Government reserves the right to conduct discussions, if necessary. The Government may reject any or all offers if such action is in the public interest, accept other than the lowest offer, and waive informalities and minor irregularities in offers received.

(f) Question Deadline. Submit all questions in writing to: Michele.Jackson@fda.hhs.gov Questions are due no later than: July 10, 2026, at 10:00 AM Eastern Time Questions received after this date may not receive a response.

(g) Quotation Deadline. Quotations are due on or before July 17, 2026, at 10:00 AM Eastern Time and must be submitted via email to Michele.Jackson@fda.hhs.gov. Please include the following in the subject line of the email [Company Name] – HFP-2026-133932 Quote

(h) Quote Format and Submission Requirements. The Contractor shall submit a firm-fixed-price quote that includes details supporting the price for all required deliverables across all five (5) categories. Quotes shall be for all deliverables requested. Discounts or other concessions are encouraged. Quotes shall be submitted in the following format: standard 8.5" x 11" page size, 1-inch margins on all sides, minimum 11-point font. Illegible or non-conforming submissions may be rejected without evaluation. Submit three separate volumes:

Volume I – Technical: Must exclude pricing. Include product specifications and compatibility documentation, confirmation of authorized Agilent reseller and/or service provider status, warranty information, proposed delivery timeline, and a description of the vendor's capability to fulfill orders across all five categories for the full five-year period of performance. Page limit: [xx] pages.

Volume II – Price: Include the completed BPA Pricing Schedule (Attachment 1, Sections A through H) with all CLIN unit prices fully loaded and inclusive of all costs associated with performance, including equipment, software, consumables, accessories, delivery, installation, labor, travel, and parts. Pricing shall include all applicable fees; any charges presented after BPA award shall not be considered acceptable.

Volume III – Past Performance References Include the completed Attachment 3 – Past Performance reference form that includes at a minimum of two references which includes a contact person name, email address, telephone number as well as the description of the supply and/or services that was provided by you the vendor to another company.

(i) Quote Content Requirements. Quotes shall clearly reference the RFQ number and include:

Date of quotation Company name Company Point of Contact name, email address, and phone number System for Award Management (SAM) Unique Entity Identifier (UEI) Confirmation of current authorized Agilent reseller and/or service provider status Quotation validity of at least 180 days after RFQ due date and time (End of provision) 52.212-2 Evaluation – Commercial Products and Commercial Services.

a) Evaluation factors. The Government will award a contract resulting from this solicitation to the Vendor responsible whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors will be used to evaluate offers:

· Technical Capability: The vendor's demonstrated ability to provide genuine Agilent OEM products and services across all five (5) categories for the full five-year period of performance, including compatibility with Government-owned Agilent Tape Station instrumentation and validated laboratory workflows, and compliance with all technical requirements specified in the attached SOW. (Pass/Fail)

· Authorized Status: Confirmation that the vendor is a current, authorized Agilent reseller and/or service provider, with the ability to maintain that status for the full five-year period of performance.

· Past Performance: The vendor must demonstrate successful delivery, installation and maintenance within the last 3 - 5 years for a Agilent 4150 Tape Station System or equivalent. (Acceptable/Neutral/Unacceptable)

· Price: Evaluated for reasonableness and completeness across all CLINs. All unit prices must be firm-fixed for the full five-year period of performance

Technical capability is significantly more important than the price.

(b) Options (if applicable). The Government will evaluate offers for award purposes by adding the total price for all options to the total price for the basic requirement. The Government may determine that an offer is unacceptable if the option prices are significantly unbalanced. The evaluation of options does not obligate the Government to exercise the option(s).

(c) Notice of award. A written notice of award or acceptance of an offer furnished to the successful vendor within the time for acceptance specified in the offer, shall result in a Blanket purchase agreement without further action by either party. Before the vendor’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award.

(End of provision)

ATTACHMENTS

Attachment 1 – BPA Pricing Schedule The BPA Pricing Schedule is provided as a separate fillable document and is incorporated herein by reference. Vendors must complete and submit the BPA Pricing Schedule in its entirety as Volume II of their quotation. All instructions contained within the pricing schedule apply and are binding on vendors.

Attachment 2 – Statement of Work (SOW) The Statement of Work is provided as a separate document. Vendors are responsible for reviewing the full SOW prior to submitting a quotation.

Attachment 3 – Past Performance Reference Form The Past Performance reference form is provided as a separate fillable document and is incorporated herein by reference. Vendors must complete and submit their past performance references as Volume III of their quotation.

Attachment 4 – SF 18 The Standard Form (SF) 18 is provided to establish a clear, documented, and legally compliant baseline for an official quote and must be signed.

Attachment 5 – Buy American Certificate (BAC) The Buy American Certificate is provided as a separate fillable document to state Buy American Act (BAA) compliance. Vendors must complete a Buy American certificate to prove compliance with the BAA. It determines your quotes eligibility, secures vital price evaluation preferences, and verifies that the materials meet required thresholds.